Isolation of mRNA - Search News

FDA rejects Moderna's mRNA flu vaccine application

U.S. Health Officials Defend Rejection of Moderna’s Flu Vaccine

The Food and Drug Administration on Wednesday backtracked on its refusal to review Moderna’s mRNA flu vaccine, while making an unusual public defense of its decisions on drug approvals.

· 3d

FDA refuses to review Moderna’s mRNA flu vaccine

· 2d · on MSN

FDA refuses to review Moderna’s application for mRNA flu vaccine, company says

· 1d

Doctor concerned FDA refusal to review mRNA flu vaccine will affect other research

The U.S. Food and Drug Administration is refusing to review Moderna’s application for approval of an mRNA-based flu vaccine, the latest step taken by the administration that might affect the use of th...

· 1d

FDA defends its decision to refuse review of Moderna's flu vaccine

· 1d

Moderna says FDA won't review its mRNA flu shot | Morning in America

NBC Chicago

Fact check: HHS misleads on mRNA vaccine safety after pulling Moderna funding

The Department of Health and Human Services has defended cuts to vaccine research with statements that mislead on the safety of mRNA technology, despite an extensive history of testing. “After a rigorous review, we concluded that continued investment in ...

Moderna: FDA RTF Derails mRNA-1010 And Reignites The Sell Case

Moderna stock is rated Sell amid FDA setbacks for mRNA-1010, commoditized COVID/RSV sales, and cash burn. Read the analysis of MRNA to assess key risks now.

Forbes

How mRNA Vaccine Platform Suffers Mainly From Manufactured Distrust

WASHINGTON, DC: Jayanta Bhattacharya, Director of the National Institutes of Health. (Photo by Andrew Harnik/Getty Images) Director of the National Institutes of Health, Jay Bhattacharya, recently stated that the mRNA technology “should not be used as a ...

GEN - Genetic Engineering and Biotechnology News

AI Will Have Profound Impact on mRNA Vaccines and Therapeutics Manufacturing

AI can help protein engineers optimize the transcription enzymes used to make mRNA-based vaccines and therapeutics, say the authors of a new study.